A new serum test for the differential diagnosis of pituitary masses

鉴别诊断垂体肿块的新血清检测

基本信息

  • 批准号:
    7629887
  • 负责人:
  • 金额:
    $ 20.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-10 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Masses of the pituitary gland (sellar masses) are common, representing approximately 15% of all intracranial masses. About half of the sellar masses are caused by a hormone-secreting adenoma and more easily diagnosed because of classical signs and symptoms. The remaining sellar masses, however, do not secrete any hormone (32% are non-functioning pituitary adenomas, and 10% are non-adenomatous lesions), and are therefore more difficult to differentiate. Often their diagnosis is established only after transsphenoidal surgery and pathological examination. Among the group of non-functioning pituitary masses, autoimmune (lymphocytic) hypophysitis is the only disease that has an immune pathogenesis. The pituitary autoantigens targeted in hypophysitis remain unknown. If discovered, they can lead to the development of a serum test useful to distinguish hypophysitis from the other non-functioning pituitary masses. This distinction is critical for patient care: in fact, hypophysitis can be usually managed medically, whereas the other conditions typically require surgery. The proposal reports our human and mouse studies aimed to discover the pituitary autoantigens and therefore develop an antibody-based serologic test for the differential diagnosis of non-functioning pituitary masses. PUBLIC HEALTH RELEVANCE: Pituitary masses are common. Because most of them do not secrete any pituitary hormone, they can often be diagnosed only after surgery and pathological examination. Autoimmune hypophysitis is the only disease entity among the non-functioning pituitary masses that has an immune pathogenesis. This grant is designed to develop an antibody- based serologic test to aid in the differential diagnosis of these common conditions. Such test could avoid unnecessary pituitary surgeries to patients with autoimmune hypophysitis.
描述(由申请人提供):垂体肿块(鞍区肿块)很常见,约占所有颅内肿块的15%。大约有一半的鞍区肿块是由垂体分泌腺瘤引起的,由于典型的体征和症状,更容易诊断。然而,其余鞍区肿块不分泌任何激素(32%为无功能垂体腺瘤,10%为非腺瘤性病变),因此更难鉴别。通常只有在经蝶手术和病理检查后才能确诊。在无功能垂体肿块组中,自身免疫性(淋巴细胞性)垂体炎是唯一具有免疫发病机制的疾病。垂体炎中靶向的垂体自身抗原仍不清楚。如果被发现,它们可以导致血清试验的发展,用于区分垂体炎和其他无功能的垂体肿块。这种区别对于患者护理至关重要:事实上,垂体炎通常可以通过药物治疗,而其他疾病通常需要手术治疗。该提案报告了我们的人类和小鼠研究,旨在发现垂体自身抗原,从而开发一种基于抗体的血清学试验,用于无功能垂体肿块的鉴别诊断。公共卫生相关性:肺结核是常见的。由于大多数垂体瘤不分泌任何垂体激素,往往要经过手术和病理检查才能确诊。自身免疫性垂体炎是无功能垂体肿块中唯一具有免疫发病机制的疾病实体。这项拨款旨在开发一种基于抗体的血清学检测,以帮助这些常见疾病的鉴别诊断。对自身免疫性垂体炎患者可避免不必要的垂体手术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRIZIO CATUREGLI其他文献

PATRIZIO CATUREGLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRIZIO CATUREGLI', 18)}}的其他基金

A new serum test for the differential diagnosis of pituitary masses
鉴别诊断垂体肿块的新血清检测
  • 批准号:
    8017624
  • 财政年份:
    2010
  • 资助金额:
    $ 20.5万
  • 项目类别:
A new serum test for the differential diagnosis of pituitary masses
鉴别诊断垂体肿块的新血清检测
  • 批准号:
    7842681
  • 财政年份:
    2009
  • 资助金额:
    $ 20.5万
  • 项目类别:
Advances in the pathogenesis of non-thyroidal illness
非甲状腺疾病发病机制的研究进展
  • 批准号:
    7554657
  • 财政年份:
    2008
  • 资助金额:
    $ 20.5万
  • 项目类别:
Advances in the pathogenesis of non-thyroidal illness
非甲状腺疾病发病机制的研究进展
  • 批准号:
    7360814
  • 财政年份:
    2008
  • 资助金额:
    $ 20.5万
  • 项目类别:
ROLE OF INTERFERON GAMMA IN THYROIDITIS
γ 干扰素在甲状腺炎中的作用
  • 批准号:
    6363047
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:
Interferon-gamma: its role in autoimmune thyroiditis and thyroid function
干扰素-γ:其在自身免疫性甲状腺炎和甲状腺功能中的作用
  • 批准号:
    7122047
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:
ROLE OF INTERFERON GAMMA IN THYROIDITIS
γ 干扰素在甲状腺炎中的作用
  • 批准号:
    6635147
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:
Interferon gamma in autoimmune thyroiditis & thyroid function
干扰素γ在自身免疫性甲状腺炎中的作用
  • 批准号:
    7265107
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:
ROLE OF INTERFERON GAMMA IN THYROIDITIS
γ 干扰素在甲状腺炎中的作用
  • 批准号:
    6042655
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:
Thyroidal Macrophages in Autoimmune Hypothyroidism and Hurthle Cells
自身免疫性甲状腺功能减退症中的甲状腺巨噬细胞和 Hurthle 细胞
  • 批准号:
    8145772
  • 财政年份:
    2000
  • 资助金额:
    $ 20.5万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 20.5万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 20.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了